Effects of supplementation with omega-3 on insulin sensitivity and non-esterified free fatty acid (NEFA) in type 2 diabetic patients
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The aim of this study was to determine the role of omega-3 supplementation on NEFA concentration, insulin sensitivity and resistance, and glucose and lipid metabolism in type 2 diabetic patients. SUBJECTS AND METHODS: Forty-four type 2 diabetic patients were randomly recruited into two groups. Group A received 4 g/day omega-3 soft gels, and group B received a placebo for 10 wks. Blood samples were collected after 12-h fast. Physical activity records, three-day food records, and anthropometric measurements were obtained from all participants at the beginning and end of the study. RESULTS: Omega-3 supplementation caused a significant reduction in NEFA in the intervention group compared with the placebo group (P = 0.009). Additionally, the administration of omega-3 resulted in significantly greater changes (Diff) for the intervention group in various parameters, such as insulin and Quicki indices compared with the placebo group (P < 0.05). CONCLUSIONS: Omega-3 fatty acid supplementation in type 2 diabetic patients improved insulin sensitivity, probably due to the decrease in NEFA concentrations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Insulin sensitivity seems to increase after supplementation of n-3 PUFAs in relation to non-esterified fatty acid reduction [27].”
From Microalgae n-3 PUFAs Production and Use in Food and Feed Industries (2021) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
Glucolipotoxicity: fuel excess and β-cell dysfunction
Poitout, V., & Robertson, R. P. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0023 · Cited by 1,092 · cited 1×
“Exposure to high NEFA concentrations causes dysfunction in glucose-stimulated insulin secretion (23).”
BackgroundFuel selection in human skeletal muscle in insulin resistance: a reexamination.
Kelley, D. E., & Mandarino, L. J. (2000) · Diabetes · doi:10.2337/diabetes.49.5.677 · Cited by 1,017
Kashyap, S., Belfort, R., Gastaldelli, A., Pratipanawatr, T., Berria, R., Pratipanawatr, W., Bajaj, M., Mandarino, L., DeFronzo, R., & Cusi, K. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2461 · Cited by 503
Fatty Acid Signaling in the β-Cell and Insulin Secretion
Nolan, C. J., Madiraju, M. S. R., Delghingaro-Augusto, V., Peyot, M.-L., & Prentki, M. (2006) · Diabetes · doi:10.2337/db06-s003 · Cited by 403
Mechanisms of Recovery From Type 2 Diabetes After Malabsorptive Bariatric Surgery
Guidone, C., Manco, M., Valera-Mora, E., Iaconelli, A., Gniuli, D., Mari, A., Nanni, G., Castagneto, M., Calvani, M., & Mingrone, G. (2006) · Diabetes · doi:10.2337/db06-0068 · Cited by 368
Meal and oral glucose tests for assessment of β-cell function: modeling analysis in normal subjects
Mari, A., Schmitz, O., Gastaldelli, A., Oestergaard, T., Nyholm, B., & Ferrannini, E. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00093.2002 · Cited by 303 · cited 1×
“NEFA concentrations as co-modulators of plasma glucose levels and insulin secretion have been used in mathematical models (6,7).”
MethodAdipose Tissue Metabolites and Insulin Resistance in Nondiabetic Asian Indian Men
Abate, N., Chandalia, M., Snell, P. G., & Grundy, S. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031843 · Cited by 201 · cited 1×
“Fish oil administration to high triglyceride, insulinresistant, or obese patients showed different and inconclusive changes in TG and NEFA, depending on the study population (28,29).”
Pownall, H. J., Brauchi, D., Kilinç, C., Osmundsen, K., Pao, Q., Payton-Ross, C., Gotto, A. M., & Ballantyne, C. M. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00301-3 · Cited by 179 · cited 1×
“So far, studies have not approved the effect of omega-3 on NEFA, but the reduction in TG levels has been explained (30).”
BackgroundFree Fatty Acids—The Link Between Obesity and Insulin Resistance
Boden, G. H. (2001) · Endocrine Practice · doi:10.4158/ep.7.1.44 · Cited by 179
Cited by
Omega-3 polyunsaturated fatty acids and their health benefits
Shahidi, F., & Ambigaipalan, P. (2018) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-111317-095850 · Cited by 1,390
Changes in Plasma Free Fatty Acids Associated with Type-2 Diabetes
I. S. Sobczak, A., A. Blindauer, C., & J. Stewart, A. (2019) · Nutrients · doi:10.3390/nu11092022 · Cited by 304
“Reduced fasting total plasma FFA levels. n-3 fatty acid Farsi et al., 2014 [250] 44 T2DM subjects Randomised, double-blind, controlled, parallel group study. n-3soft gels 4 g/day for 10 weeks.”
BackgroundInfluentialMicroalgae n-3 PUFAs Production and Use in Food and Feed Industries
Remize, M., Brunel, Y., Silva, J. L., Berthon, J.-Y., & Filaire, E. (2021) · Marine Drugs · doi:10.3390/md19020113 · Cited by 214
“Insulin sensitivity seems to increase after supplementation of n-3 PUFAs in relation to non-esterified fatty acid reduction [27].”
BackgroundImplicating the effect of ketogenic diet as a preventive measure to obesity and diabetes mellitus
Kumar, S., Behl, T., Sachdeva, M., Sehgal, A., Kumari, S., Kumar, A., Kaur, G., Yadav, H. N., & Bungau, S. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118661 · Cited by 173
Role of phytochemicals in the management of metabolic syndrome
Cicero, A. F. G., & Colletti, A. (2015) · Phytomedicine · doi:10.1016/j.phymed.2015.11.009 · Cited by 162
Insulin-sensitizing effects of omega-3 fatty acids: lost in translation?
Lalia, A., & Lanza, I. (2016) · Nutrients · doi:10.3390/nu8060329 · Cited by 141
“2014 [118] Effect of FO on IS and NEFA, n = 44 4 g/day 2.”
BackgroundFish oil supplementation and insulin sensitivity: a systematic review and meta-analysis
Gao, H., Geng, T., Huang, T., & Zhao, Q. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0528-0 · Cited by 140
“Our results were consistent with the meta-analysis reported in 2011 showing that fish oil supplementation had no effects on insulin sensitivity; however, among participants with metabolic syndrome, fish oil is associated with lower risk of insulin resistance [16, 40].”
ResultOmega-3 long-chain polyunsaturated fatty acids: Metabolism and health implications
Khan, I. R., Hussain, M., Jiang, B., Zheng, L., Pan, Y., Hu, J., Khan, A., Ashraf, A., & Zou, X. (2023) · Progress in Lipid Research · doi:10.1016/j.plipres.2023.101255 · Cited by 138
Omega-3 supplementation and diabetes: A systematic review and meta-analysis
Delpino, F. M., Figueiredo, L. M., da Silva, B. G. C., da Silva, T. G., Mintem, G. C., Bielemann, R. M., & Gigante, D. P. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1875977 · Cited by 277
Papuc, C. P., GORAN, G. V., Predescu, N. C., Tudoreanu, L., & Ștefan, G. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1815644 · Cited by 77
Azuma, M. M., Gomes‐Filho, J. E., Ervolino, E., Pipa, C. B., Cardoso, C. D. B. M., Andrada, A. C., Kawai, T., & Cintra, L. T. Â. (2017) · Journal of Endodontics · doi:10.1016/j.joen.2017.01.006 · Cited by 55
“Omega 3 polyunsaturated fatty acids (u-3 PUFAs), as represented by eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have been accepted as an adjuvant therapy in the treatment of chronic inflammatory diseases such as rheumatoid arthritis (3), cardiovascular disease (4), and diabetes (5).”
BackgroundHashemzadeh, A. A., Nasoohi, N., Raygan, F., Aghadavod, E., Akbari, E., Taghizadeh, M., Memarzadeh, M. R., & Asemi, Z. (2017) · Lipids · doi:10.1007/s11745-017-4295-5 · Cited by 56
de Souza, D. R., Pieri, B. L. D. S., Comin, V. H., Marques, S. D. O., Luciano, T. F., Rodrigues, M. S., & de Souza, C. T. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107553 · Cited by 51
The role of polyunsaturated fatty acids (n-3 PUFAs) on the pancreatic β-cells and insulin action
Baynes, H. W., Mideksa, S., & Ambachew, S. (2018) · Adipocyte · doi:10.1080/21623945.2018.1443662 · Cited by 56
“It resulted for the decrement of non-esterified free fatty acid concentrations which further improved insulin sensitivity in type 2 diabetic patients [21].”
BackgroundMohan, V., Narasimhan, S., Lakshmipriya, N., Vaidya, R., Gunasekaran, G., Gayathri, R., Vijayalakshmi, P., Unnikrishnan, R., Anjana, R., & Sudha, V. (2015) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.172248 · Cited by 43
Itsiopoulos, C., Marx, W., Mayr, H. L., Tatucu-Babet, O. A., Dash, S. R., George, E. S., Trakman, G. L., Kelly, J. T., Thomas, C. J., & Brazionis, L. (2018) · Journal of Nutrition & Intermediary Metabolism · doi:10.1016/j.jnim.2018.02.002 · Cited by 37
“inconsistent results, with omega-3 PUFA supplementation found to both decrease [29] and improve [30] insulin sensitivity.”
ResultThe risk of metabolic syndrome as a result of lifestyle among Ellisras rural young adults
Sekgala, M. D., Monyeki, K. D., Mogale, A., Mchiza, Z. J., Parker, W., Choma, S., & Makgopa, H. M. (2018) · Journal of Human Hypertension · doi:10.1038/s41371-018-0076-8 · Cited by 31
“Food rich in PUFA increases insulin sensitivity [50], glucose utilization and decreases insulin resistance and the risk of type 2 diabetes [51].”
BackgroundJadhav, H. B. (2024) · Food Chemistry Advances · doi:10.1016/j.focha.2024.100695 · Cited by 29
Kim, Y., Oh, Y. K., Lee, J., & Kim, E. Y. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01374-6 · Cited by 23
“2019), omega-3 fatty acids (FAs) (n = 26) (Schectman et al. 1988; Borkman et al. 1989; Hendra et al. 1990; McVeigh et al. 1993; Westerveld et al. 1993; Morgan et al. 1995; Puhakainen et al. 1995; McManus et al. 1996; Rivellese et al. 1996; Luo et al. 1998; Kabir et al. 2007; Shidfar et al. 2008; Pooya et al. 2010; Won…”
Effects of dietary palm olein on the cardiovascular risk factors in healthy young adults
Lv, C., Wang, Y., Zhou, C. L., Ma, W., Yang, Y., Xiao, R., & Yu, H. (2018) · Food & Nutrition Research · doi:10.29219/fnr.v62.1353 · Cited by 22
“Whereas pervious study has reported that Omega-3 supplementation caused a significant reduction in NEFA in the intervention group compared with the placebo group (34).”
Marei, W. F. A., Arias‐Álvarez, M., Hoeck, V. V., Gutiérrez‐Adán, A., Bols, P. E. J., & Leroy, J. (2016) · Reproduction Fertility and Development · doi:10.1071/rd16297 · Cited by 19
Sivaramakrishnan, R., Kanwal, S., Incharoensakdi, A., Nirmal, N. P., & Srimongkol, P. (2025) · Journal of Agriculture and Food Research · doi:10.1016/j.jafr.2025.102148 · Cited by 28
Curioni, C. C., Alves, N. N. R., & Zago, L. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.11.016 · Cited by 16
Regan-Smith, S., Fritzen, R., Hierons, S. J., Ajjan, R., Blindauer, C. A., & Stewart, A. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810302 · Cited by 9
“assessed the effect of supplementing the diet of diabetes patients with multiple omega-3 fatty acids in soft gel form [71].”
BackgroundJan, D. L., Misha, M. S., Destrumelle, S., Terceve, O., Thorin, C., Larcher, T., Ledevin, M., Desfontis, J., Betti, É., & Mallem, Y. (2024) · Biology · doi:10.3390/biology13121070 · Cited by 7
“Moreover, supplementation in type II diabetic patients improves their insulin sensitivity by reducing non-esterified free fatty acids [39].”
Halfen, S., Jacometo, C. B., Mattei, P., Fenstenseifer, S. R., Pfeifer, L. F. M., Pino, F. A. B. D., dos Santos, M. A. Z., de Pereira, C. M. P., Schmitt, E., Corrêa, M. N., et al. (2016) · Brazilian Archives of Biology and Technology · doi:10.1590/1678-4324-2016150549 · Cited by 6
Is There Something Fishy About Fish Oil?
Šunderić, M., Robajac, D., Gligorijević, N., Miljuš, G., Nedić, O., Smilkov, K., Ackova, D. G., Rudić-Grujić, V., & Penezić, A. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190705185800 · Cited by 5
Guraka, A., Sreedharan, S., Arasaradnam, R. P., Tripathi, G., & Kermanizadeh, A. (2024) · Nutrition Reviews · doi:10.1093/nutrit/nuae172 · Cited by 5
Dietary Supplements Derived from Food By-Products for the Management of Diabetes Mellitus
Yuksek, E. N., Pereira, A. G., & Prieto, M. A. (2025) · Antioxidants · doi:10.3390/antiox14101176 · Cited by 8
“As a result, T2DM patients had a better glucose metabolism and a reduced burden on pancreatic insulin production [176].”
Health Benefits of Fish Oil and the Application of Encapsulated Fish Oil in Meat and Dairy Products
Turp, G., & Özüesen, S. (2025) · Marine Science and Technology Bulletin · doi:10.33714/masteb.1635847 · Cited by 2
Beneficial effects of long-chain n-3 fatty acids on insulin-resistance: basic and clinical aspects
Delarue, J. (2025) · Biochimie · doi:10.1016/j.biochi.2025.09.014 · Cited by 183
The effect of herbal salt as a natural antioxidant in preserving fish during freezing storage
Lira, G. M., López, A. M. Q., NANES, G. M. D. F., Silva, F. G. C., & do Nascimento, T. G. (2020) · Food Science and Technology · doi:10.1590/fst.31420 · Cited by 2
Acides gras polyinsaturés à longue chaîne n-3 et insulino-résistance
Delarue, J., & Guriec, N. (2016) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(16)30168-7 · Cited by 3
Génétique, acides gras oméga-3 et facteurs de risque des maladies cardiovasculaires
Bouchard‐Mercier, A. (2015) · Corpus Université Laval (Université Laval)
O’Keefe, S. F., & Ambigaipalan, P. (2020) · Wiley eBooks · doi:10.1002/047167849x.bio099
Caressa, D. A., Adi, A. C., Adiningsih, S. H., Purwoto, S. P., & Pranoto, A. (2022) · Indonesian Journal of Human Nutrition · doi:10.21776/ub.ijhn.2022.009.01.3
Role of Omega-3 Fatty Acid in Type 2 Diabetes: A Clinical Perspective
Pakale, A. M., Tiwari, S., & Unnikrishnan, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-84200-9_18
Takebayashi-Caballero, N., Rico-Chávez, A. K., Reynoso‐Camacho, R., Feregrino‐Pérez, A. A., Castaño, V. M., Amaya‐Llano, S. L., & Regalado‐González, C. (2026) · Investigación y Desarrollo en Ciencia y Tecnología de Alimentos · doi:10.29105/idcyta.v11i2.163
Quattrone, A., Fehri, N. E., Barbato, O., Ricci, G., Vigo, D., Turmalaj, L., Sulçe, M., Castrica, M., Marongiu, M. L., Bosco, A. D., et al. (2026) · Veterinary Quarterly · doi:10.1080/01652176.2026.2749322
“…models, where their bioactive constituents have been shown to reduce circulating free fatty acids through modulation of adipose tissue lipolysis, stimulation of fatty acid oxidation, and regulation of lipid metabolism (Farsi et al. 2014; Jump et al. 2018; Yuan et al. 2020; Pandey et al. 2025).”
Metadata
- Authors
- Farsi, P. F., Djazayery, A., Eshraghian, M. R., Koohdani, F., Saboor-Yaraghi, A. A., Derakhshanian, H., Zarei, M., Javanbakht, M. H., & Djalali, M.
- Affiliations
- Tehran University of Medical Sciences, Iran; Tehran University of Medical Sciences, Iran
- Tehran University of Medical Sciences (IR)
- ORCID
- Venue
- Arquivos Brasileiros de Endocrinologia & Metabologia
- Publisher
- FapUNIFESP (SciELO)
- Published
- 2014-06
- Volume
- 58
- Issue
- 4
- Pages
- 335-340
- ISSN
- 0004-2730 (ISSN-L)
- OpenAlex
- W2000670766
- Cited by
- 40
- References
- 31
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 4 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 5 · 2019: 2 · 2018: 6 · 2017: 3 · 2016: 4 · 2015: 3
- FWCI
- 3.10
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc
- Locations
- Arquivos Brasileiros de Endocrinologia & Metabologia (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- Americanae (AECID Library) (submittedVersion, cc-by-nc)
- Funders
- Tehran University of Medical Sciences and Health Services
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- omega-3 fatty acids, dietary supplementation, type 2 diabetes, insulin sensitivity, insulin resistance, free fatty acids, glucose metabolism, lipid metabolism
- MeSH terms
- Adult, Analysis of Variance, Blood Glucose, Diabetes Mellitus, Type 2, Dietary Carbohydrates, Double-Blind Method, Fatty Acids, Nonesterified, Female, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Cholesterol, HDL, Cholesterol, LDL, Male, Middle Aged, Triglycerides, Fatty Acids, Omega-3, Body Mass Index, Dietary Supplements, Lipid Metabolism, Waist Circumference
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.